guselkumab (tremfya) Report issue

Biologics mAb Approved FDA First in Class
AACT ChEMBL DrugBank Drugs@FDA
Back

Drug Pricing Summary

AUS PBS

$2859.8956

VA Big4

$7942.3100 - $8037.1400

VA FSS

$10842.2800

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
guselkumab 100 mg / 1 mL (1 mL INJECTION) $2859.8956 AUS PBS generic
  • Tremfya (1)
    		•  Janssen-Cilag Pty Ltd
    guselkumab 100 mg / 1 mL (1 mL INJECTION) $7942.3100 VA Big4
  • Tremfya (1)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    guselkumab 100 mg / 1 mL (1 mL INJECTION) $8037.1400 VA Big4
  • Tremfya (1)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
    guselkumab 100 mg / 1 mL (1 mL INJECTION) $10842.2800 VA FSS
  • Tremfya (1)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.
  • Tremfya (1)
    		•  J & J Health Care Systems on behalf of Janssen Biotech Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue